Published in Am J Gastroenterol on September 01, 2003
Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut (2007) 1.21
Patient compliance based on genetic medicine: a literature review. J Community Genet (2013) 1.04
Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population. Am J Hematol (2008) 0.98
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology (2010) 0.88
Accuracy of family history of hemochromatosis or iron overload: the hemochromatosis and iron overload screening study. Clin Gastroenterol Hepatol (2008) 0.82
Aceruloplasminemia: a rare disease - diagnosis and treatment of two cases. Rev Bras Hematol Hemoter (2011) 0.82
Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity. BMC Med Genet (2006) 0.78
Potential nonresponse bias in a clinical examination after initial screening using iron phenotyping and HFE genotyping in the hemochromatosis and iron overload screening study. Genet Test Mol Biomarkers (2009) 0.75
Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis. Blood Transfus (2013) 0.75
Ruxolitinib for the treatment of patients with polycythemia vera. Expert Rev Hematol (2015) 0.75
Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med (2005) 5.78
Blood pressure reactivity to psychological stress and coronary calcification in the Coronary Artery Risk Development in Young Adults Study. Hypertension (2006) 1.86
Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci (2003) 1.76
Biological variability of transferrin saturation and unsaturated iron-binding capacity. Am J Med (2007) 1.72
Haemochromatosis. Lancet (2007) 1.63
Randomized pilot of a self-guided internet coping group for women with early-stage breast cancer. Ann Behav Med (2005) 1.60
Concerns in a primary care population about genetic discrimination by insurers. Genet Med (2005) 1.48
HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study. Circ Cardiovasc Genet (2009) 1.45
Management of hemochromatosis in a Jehovah's Witness. Am J Hematol (2005) 1.41
Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med (2003) 1.33
Genetic screening for iron overload: No evidence of discrimination at 1 year. J Fam Pract (2007) 1.27
Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis (2003) 1.24
Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood (2004) 1.20
Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. Diabetes Care (2006) 1.20
Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol (2008) 1.19
Treatment preferences in recurrent ovarian cancer. Gynecol Oncol (2002) 1.14
How I treat hemochromatosis. Blood (2010) 1.13
Serum ferritin and transferrin saturation in Asians and Pacific Islanders. Arch Intern Med (2007) 1.12
Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Ethn Dis (2006) 1.02
Liver diseases in the hemochromatosis and iron overload screening study. Clin Gastroenterol Hepatol (2006) 1.02
Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population. Am J Hematol (2008) 0.98
HAMP promoter mutation nc.-153C>T in 785 HEIRS study participants. Haematologica (2009) 0.97
Use of the internet for information and support: disclosure among persons with breast and prostate cancer. J Behav Med (2004) 0.96
Impact of hemochromatosis screening in patients with indeterminate results: the hemochromatosis and iron overload screening study. Genet Med (2006) 0.95
Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study. Can J Gastroenterol (2009) 0.95
Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study. Am J Hematol (2007) 0.94
Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants. Blood Cells Mol Dis (2009) 0.92
Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis. Br J Haematol (2004) 0.92
A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. J Hepatol (2011) 0.90
Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damage. Am J Gastroenterol (2003) 0.89
Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study. Hepatology (2012) 0.89
Social, demographic, and medical influences on physical activity in child and adolescent cancer survivors. J Pediatr Psychol (2011) 0.88
Three kinships with ALAS2 P520L (c. 1559 C --> T) mutation, two in association with severe iron overload, and one with sideroblastic anemia and severe iron overload. Blood Cells Mol Dis (2006) 0.88
Results communication and patient education after screening for possible hemochromatosis and iron overload: experience from the HEIRS Study of a large ethnically and linguistically diverse group. Genet Med (2007) 0.86
Patient acceptability of genotypic testing for hemochromatosis in primary care. Genet Med (2005) 0.86
Countries of ancestry reported by hemochromatosis probands and control subjects in central Alabama. Ethn Dis (2004) 0.86
Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol Dis (2007) 0.85
SLC40A1 c.1402G-->a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype. Acta Haematol (2007) 0.85
Improving the effectiveness of adjuvant psychological treatment for women with breast cancer: the feasibility of providing online support. Psychooncology (2004) 0.84
Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia. Blood (2011) 0.84
Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study. Am J Hematol (2010) 0.83
Survey of physician knowledge about hemochromatosis. Genet Med (2002) 0.83
Cognitive influences as mediators of family and peer support for pediatric cancer survivors' physical activity. Psychooncology (2012) 0.83
Mild iron overload in an African American man with SLC40A1 D270V. Acta Haematol (2012) 0.82
Accuracy of family history of hemochromatosis or iron overload: the hemochromatosis and iron overload screening study. Clin Gastroenterol Hepatol (2008) 0.82
Psychosocial impact of genetic testing for hemochromatosis in the HEIRS Study: a comparison of participants recruited in Canada and in the United States. Genet Test (2007) 0.81
Multi-organ iron overload in an African-American man with ALAS2 R452S and SLC40A1 R561G. Acta Haematol (2008) 0.80
Angioedema associated with imiquimod. J Am Acad Dermatol (2004) 0.80
The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol Dis (2004) 0.80
Mixture models of serum iron measures in population screening for hemochromatosis and iron overload. Transl Res (2006) 0.80
Serum ferritin, insulin resistance, and metabolic syndrome: clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS study. Metab Syndr Relat Disord (2014) 0.80
Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R. Acta Haematol (2006) 0.79
Ancestry reported by white adults with cutaneous melanoma and control subjects in central Alabama. BMC Cancer (2004) 0.79
Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease. Neurobiol Aging (2006) 0.78
Purification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia. Br J Haematol (2008) 0.78
Common TMPRSS6 mutations and iron, erythrocyte, and pica phenotypes in 48 women with iron deficiency or depletion. Blood Cells Mol Dis (2012) 0.78
Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. J Clin Gastroenterol (2009) 0.78
Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) study. Genet Med (2007) 0.78
Perceptions and attitudes about HFE genotyping among college-age adults. J Genet Couns (2005) 0.78
African Americans at risk for increased iron stores or liver disease. Am J Med (2007) 0.78
HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L. Can J Gastroenterol (2013) 0.77
Attitudes about and psychosocial outcomes of HFE genotyping for hemochromatosis. Genet Test (2004) 0.77
Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Transl Res (2007) 0.76
Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients. Hematology (2003) 0.76
Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia. Am J Hematol (2002) 0.76
Serum immunoglobulins in 28 adults with autoimmune sensorineural hearing loss: increased prevalence of subnormal immunoglobulin G1 and immunoglobulin G3. BMC Immunol (2014) 0.75
Potential nonresponse bias in a clinical examination after initial screening using iron phenotyping and HFE genotyping in the hemochromatosis and iron overload screening study. Genet Test Mol Biomarkers (2009) 0.75
Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants. Blood Cells Mol Dis (2010) 0.75
The effect of preventability and severity levels of a genetic disorder on desire to communicate genetic testing information to family members. Genet Test (2005) 0.75
Sideroblastic anemia, iron overload, and ALAS2 R452S in African-American males: phenotype and genotype features of five unrelated patients. Am J Hematol (2011) 0.75
Bilateral subdural hematomas in an adult with hereditary factor VII deficiency: A complication of sit-ups and inversion? Clin Appl Thromb Hemost (2007) 0.75
Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer. Clin Breast Cancer (2007) 0.75
Genetic testing for hemochromatosis: attitudes and acceptability among young and older adults. Genet Test (2003) 0.75